Tenovi has filed a notice of an exempt offering of securities to raise $4,182,455.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Tenovi is raising $4,182,455.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nizan Friedman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Tenovi
Tenovi provides proprietary hardware and software needed to power remote monitoring programs with the first plug and play cellular gateway, a growing suite of FDA approved user friendly devices, and an intuitive clinician software portal. Low patient adherence kills remote patient monitoring programs. Our platform increases the number of patients eligible for Medicare CPT 99454 reimbursement by 27% when compared to leading cellular RPM devices. Choose from a growing list of FDA approved Bluetooth RPM devices with industry leading accuracy. Tenovi Cellular Gateway uses cellular technology to automatically send patient data to the Tenovi cloud. Use our Tenovi RPM Dashboard or send data directly to your software platform through our API.
To learn more about Tenovi, visit http://tenovi.com/
Contact:
Nizan Friedman, Chief Executive Officer
714-418-5658
https://www.linkedin.com/in/nizanf/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.